This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC

CPC September 2021 programme

Subpage Hero

.

Loading

Reversing DOAC Bleeding: How has the management of life-threatening bleeds changed?

24 Sep 2021
Clinical Leadership Theatre
Reversing DOAC Bleeding: How has the management of life-threatening bleeds changed?

Join Dr. Amir Jehangir to discuss the key role of pharmacists in reversing FXa inhibitor-related life-threatening or uncontrolled bleeds. An overview of the products currently being used to reverse bleeds will be discussed alongside a summary of the ANNEXA-4 clinical trial and an example of the multidisciplinary team involved in adding a new reversal agent to a hospital formulary. The practical implications of administering such a product will also be explained.

Partners

Lead Education Partner

  • CPPE
  • Morph

 

Education Partner

  • APTUK
  • BOPA
  • BPNG
  • CMHP
  • Health Education England

 

Education Partner

  • HIVPA
  • UKRPG
  • NHS England and NHS Improvement
  • NHS Digital
  • NHSx
  • PTOC
  • GPHC

 

Education Partner

  • NPPG
  • PCPA
  • PDA
  • Pharmacist Support
  • RPUK
  • SPS

 

Education Partner

  • Soar Beyond
  • NHCA
  • UKBPA
  • UKCPA
  • PrescQIPP
  • Pharmacy Declares
  • GHP and RPS

 

Media Partner

  • C&D
  • PDA
  • PrescQIPP
  • Scottish Healthcare Review
  • Welsh Healthcare Review
  • NI Healthcare Review
  • Prescriber

 

Nominated Charity

  • Pharmacist Support

 

Newsletter Sign Up